Expertise in
1
conditions

Fred Witjes

Nijmegen, GE, NL 
Expertise in
1
conditions
Nijmegen, GE, NL 

Overview

Fred Witjes practices practicing medicine in Nijmegen, Netherlands.

Mr. Witjes is highly rated in 1 condition, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Urothelial Cancer, and Cystectomy.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Nijmegen, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma A Multicenter, Prospective Blinded Study
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma A Multicenter, Prospective Blinded Study
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Other
Study Phase: Not Applicable
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Device
View 1 Less Clinical Trial

9 Total Publications

Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.
Journal: BJU international
Published: April 06, 2026

Frequently Asked Questions about Fred Witjes

Is Fred Witjes a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Fred Witjes is classified as an Advanced expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fred Witjes participate in research or clinical trials?

Yes. Fred Witjes has published 9 articles and abstracts on conditions like Bladder Cancer. You can view a list of Fred Witjes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Witjes's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile